lapatinib has been researched along with thiostrepton in 1 studies
Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (thiostrepton) | Trials (thiostrepton) | Recent Studies (post-2010) (thiostrepton) |
---|---|---|---|---|---|
1,919 | 305 | 1,442 | 353 | 1 | 144 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chaluvally-Raghavan, P; Geethadevi, A; George, J; Gopinadhan Nair, GK; Kadamberi, IP; Lu, Y; Mills, GB; Nair, A; Nair, B; Parashar, D; Pradeep, S; Rader, JS; Ram, PT; Ramchandran, R; Tsaih, SW; Uyar, DS | 1 |
1 other study(ies) available for lapatinib and thiostrepton
Article | Year |
---|---|
Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 Signaling.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; ErbB Receptors; Female; Forkhead Box Protein M1; Gene Knockdown Techniques; Humans; Lapatinib; Mice; Ovarian Neoplasms; Peritoneal Neoplasms; Receptor, ErbB-2; Signal Transduction; Thiostrepton; Transfection | 2020 |